Welcome to Bellberry!
Bellberry HRECs provide high quality, independent ethics reviews. With eight committee meetings held every month we are able to offer an approximate turnaround time of 20 working days from submission of application to review decision. Dedicated staff provide support at every stage of the process.
In 2009 as part of Bellberry’s commitment to continual business and quality improvement, we implemented an online submission system called eProtocol. eProtocol provides a common tool for principal investigators and research staff to prepare, submit, review, and communicate about research protocols.
Bellberry provide review for social science and observational studies as well as clinical drug trials.
Why Come to Bellberry for independent ethical review?
Bellberry’s Committees have reviewed well over 1,000 studies since its beginnings in 2004 including approximately a third of all clinical studies registered with the Therapeutic Goods Administration in recent years. Bellberry Committees are able to review all phases of clinical drug trials and social science studies. They currently review on average 38 studies per month (2018/19). With over 100 Committee members throughout Australia and a pool of experts supporting our Committees, we are well placed to provide in depth and robust review of research studies.
Our focus in the HREC review process is on Quality and Timeliness of Review, and our turnaround time is approximately 20 working days from submission of application to the review decision (this does not include the time the application is back with the investigator). Bellberry was recognised by the 2012 McKeon Review as “setting the benchmark” for Australian HREC review services.
Also see Bellberry Benefits
To access the eProtocol system you will require a user name and password. In order to obtain these please complete the registration on the eProtocol log in page and then visit our Getting Started pages
The How to Apply information will provide you with a quick overview of how to lodge an application.